Advanced Diagnostics Accelerator

Members of the clinical team outside the mobile liver assessment clinic during the ID LIVER project.
Background
The Advanced Diagnostics Accelerator (ADA) is a series of projects that looks to address Greater Manchester’s major morbidities.
The ADA is funded by Innovate UK and is part of the Health Innovation Accelerator. It has been set up to rapidly improve the diagnosis and treatment of disease across the 2.8m Greater Manchester population. The project is delivered by Manchester University NHS Foundation Trust (MFT), The University of Manchester, and industry partners.
ID LIVER is one of the key projects within this programme. It builds on the work and expertise developed through the original Innovate UK funded project. It aims to develop a targeted and streamlined approach to identifying, assessing and managing patients at increased risk of liver disease.
Using technology to tackle liver disease in Manchester
Liver disease disproportionally affects certain communities more than others. It is closely linked with social deprivation, people with two or more long-term health conditions (multimorbidity), obesity and alcohol use.
As part of the project, the team are using technology to help tackle liver disease. This includes:
- Analysing data and statistics about population health to identify underserved communities in Greater Manchester that are most affected by liver disease.
- Exploring how Artificial Intelligence (AI) and Machine Learning (ML) can streamline liver disease diagnostic pathways.
Early detection of liver disease can save money for the NHS by taking a more targeted approach. This will also help tackle health inequalities in high-risk groups.
How we involve patients
Patients at increased risk of liver disease are invited to attend a liver health check in a community setting. Here, they have series of tests in one visit and during the appointment, patients are asked if they would like to participate in the ID LIVER study.
Patients provide helpful information that allows the research team to develop new, improved tests for detecting liver disease earlier and predicting disease progression.
Raising awareness
In addition to early detection, an important element of this project is raising awareness of liver disease amongst underserved and marginalised groups. Working in partnership with communities, the project aims to co-design communications and learn how liver assessment clinics can best be provided in different community settings.
Through this community collaboration we will ensure that innovative solutions are applied to address health inequalities.